Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Clinical Characteristics and Outcomes in Patients with Coronavirus Disease 2019 and Multiple Sclerosis

Research Alert

Newswise — Background: Risk factors associated with the severity of COVID-19 in patients with multiple sclerosis (MS) begin to be identified from several cohort studies. Disease modifying therapies (DMTs) may modify the risk of developing a severe COVID-19 infection, beside identified risk factors such as age and comorbidities.

Objectives: The objective was to describe the clinical characteristics and outcomes in patients with COVID-19 and to identify the factors associated with COVID-19 severity.

Methods: This multicenter, retrospective, observational cohort study (COVISEP registry, NCT04355611) included patients with MS presenting with a confirmed or highly suspected diagnosis of COVID-19 between March 1, 2020 and July 14, 2020. The main outcome was COVID-19 severity assessed on a 7-point ordinal scale (ranging from 1: not hospitalized, no limitations on activities, to 7: death; cutoff at 3: hospitalized, not requiring supplemental oxygen). We collected demographics, neurological history, Expanded Disability Severity Score (EDSS), comorbidities, COVID-19 characteristics and outcome. Univariate and multivariate logistic regression models were used to estimate the influence of collected variables on COVID-19 outcome.

Results: A total of 405 patients (mean age: 44.7 years, female/male: 293/112, mean disease duration: 13.4 years) were analyzed. Seventy-eight patients (19.3%) had a COVID-19 severity score ≥ 3, and 12 patients (3.0%) died from COVID-19. Median EDSS was 2.0 (range: 0-9.5), 326 patients (80.5%) were on DMT. There was a higher proportion of patients with COVID-19 severity score ≥ 3 among patients with no DMT relative to patients on DMTs (39.2% versus 14.4%, p<0.001). Multivariate logistic regression models determined that age (OR for 10 years: 1.8, 95% CI: 1.4-2.4), EDSS (OR for EDSS ≥ 6: 4.5, 95% CI: 2.0-10.0) were independent risk factors for COVID-19 severity score ≥ 3 (hospitalization or higher severity) while immunomodulatory treatment (interferon or glatiramer acetate) was associated with lower risk of COVID-19 severity score ≥ 3 (OR: 0.2, 95% CI: 0.05-0.8). EDSS was associated with the highest variability of COVID-19 severe outcome (R2= 0.18), followed by age (R2= 0.06) and immunomodulatory treatment (R2= 0.02).

Conclusions: EDSS and age were independent risk factors of severe COVID-19, while exposure to immunomodulatory DMTs (interferon and glatiramer acetate) were independently associated with lower COVID-19 severity. We did not find an association between other DMTs exposure (including immunosuppressive therapies) and COVID-19 severity. The identification of these risk factors should provide the rationale for an individual strategy regarding clinical management of MS patients during the COVID-19 pandemic.

Presenter: Celine Louapre, Pitié-Salpêtrière hospital, APHP, Neurology




Filters close

Showing results

110 of 3730
Newswise: 246543_web.jpg
Released: 21-Oct-2020 2:45 PM EDT
Observed COVID-19 variability may have underlying molecular sources
University of California, Riverside

People have different susceptibilities to SARS-CoV-2, the virus behind the COVID-19 pandemic, and develop varying degrees of fever, fatigue, and breathing problems -- common symptoms of the illness. What might explain this variation?

Released: 21-Oct-2020 2:10 PM EDT
Hospitals Leaned Toward Strict COVID-19 NICU Policies Despite Low Prevalence of Infection, New Study Finds
George Washington University

Two studies examining the impact of COVID-19 on neonatal intensive care units (NICUs) found the prevalence of COVID-19 in NICU infants is low, yet many hospitals at the start of the pandemic put in place strict parental visitation policies and scaled back NICU services such as lactation support and therapy.

Newswise: Tracking the SARS-CoV-2 Virus with Genome Sequencing
Released: 21-Oct-2020 2:05 PM EDT
Tracking the SARS-CoV-2 Virus with Genome Sequencing
University of North Carolina School of Medicine

Dirk Dittmer, PhD, professor of microbiology and immunology at the UNC School of Medicine, is tracking the virus that causes COVID-19 by sequencing the genome of virus samples collected from diagnostic testing. Using next generation sequencing on SARS-CoV-2 will help accurately diagnose the novel coronavirus, identify mutations and track its history.

Released: 21-Oct-2020 12:55 PM EDT
Study assessing how early childhood educators spend time away from students
University of Nebraska-Lincoln

Much attention is paid to the work early childhood teachers do in the classroom, but their tasks away from their students can be just as essential to children’s learning and development.

Released: 21-Oct-2020 12:50 PM EDT
Rutgers Pediatricians Sound Alarm on Decreased Flu Vaccinations, Immunizations for Children
Rutgers University-New Brunswick

Two Rutgers New Jersey Medical School pediatricians discuss the importance of keeping children and adults up to date with immunizations during the coronavirus crisis.

Released: 21-Oct-2020 11:35 AM EDT
Trump's claim that House Speaker Nancy Pelosi is to blame for the stalled COVID-19 stimulus legislation is not accurate
Newswise

President Donald Trump has repeatedly blamed the U.S. House Speaker Nancy Pelosi for "not caring about Americans" since she would not agree to his terms for COVID-19 relief aid. We rate these claims as mostly false because they are misleading. According to the New York Times, Senator Mitch McConnell, Republican of Kentucky and the majority leader, told Republican senators privately on Tuesday that he has advised the White House not to strike a deal with Speaker Nancy Pelosi on a new stimulus bill before Election Day.

access_time Embargo lifts in 2 days
Embargo will expire: 24-Oct-2020 5:00 PM EDT Released to reporters: 21-Oct-2020 11:10 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 24-Oct-2020 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 21-Oct-2020 10:50 AM EDT
COVID-19 Model Inspired by Gas-Phase Chemistry Predicts Disease Spread
Rensselaer Polytechnic Institute (RPI)

A COVID-19 transmission model inspired by gas-phase chemistry is helping the Centers for Disease Control and Prevention (CDC) forecast COVID-19 deaths across the country. Developed by Yunfeng Shi, an associate professor of materials science and engineering at Rensselaer Polytechnic Institute, and Jeff Ban, a professor of civil engineering at the University of Washington, the model uses fatality data collected by Johns Hopkins University and mobility data collected by Google to predict disease spread based on how much a population is moving within its community.

Released: 21-Oct-2020 10:45 AM EDT
Americans’ Responses to Covid-19 Stay-Home Orders Differed According to Population Density
Johns Hopkins Bloomberg School of Public Health

Americans strongly reduced their visits to grocery stores, pharmacies, and transit stations following stay-at-home orders from mayors and governors earlier this year, but did not reduce their visits to parks and beaches.


Showing results

110 of 3730

close
1.20696